Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Accelerated rTMS for Psychomotor Slowing [NA]
A University of Bern-sponsored clinical trial evaluating accelerated rTMS for psychomotor slowing in schizophrenia-related disorders has bee…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
This clinical trial update assesses regulatory compliance for hematological monitoring in patients treated with clozapine, with relevance to…
-
FDA approval · 2024-09-24FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Devatis, Inc.)
The FDA approved Devatis, Inc.'s original application for chlorpromazine hydrochloride, a generic antipsychotic. It covers a generic product…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Aspirin in Young Psychotic Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating aspirin in young patients with psychosis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: EVEN - Effects of VR on Empathy for Nature in Patients with Psychosis and Depressive Disorders
A completed clinical trial evaluating the effects of virtual reality on empathy for nature in patients with schizophrenia or depressive diso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Enhancing Psychiatric Nursing Skills in Auditory Hallucination Assessment Via AR/VR and Virtual OSCE [NA]
A randomized controlled trial protocol evaluating AR/VR and virtual OSCE-based training to improve psychiatric nurses' assessment of auditor…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications [Phase 2]
Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of Miricorilant (CORT118335) in obese adults with schizophrenia or bipolar d…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect and Cost-effectiveness of the Everyday Life Rehabilitation Intervention [NA]
This update reports the completion of a study evaluating the effectiveness and cost-effectiveness of the Everyday Life Rehabilitation Interv…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 [NA]
This clinical trial update reports the completion and posting of results for Study 2 evaluating transcranial direct current stimulation to e…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Neuroplasticity in TBI and Schizophrenia [NA]
A completed clinical trial evaluating neuroplasticity in schizophrenia and traumatic brain injury has posted results. Results are publicly a…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia [NA]
A clinical trial is evaluating Virtual Reality-based therapy to treat negative symptoms in schizophrenia and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Personalized Psychological Treatment for Psychosis [NA]
This clinical trial update describes the Personalized Psychological Treatment for Psychosis study, a non-pharmacologic intervention for schi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Treatment of Negative Symptoms of Schizophrenia by rTMS [NA]
Clinical trial update notes an ongoing study evaluating repetitive transcranial magnetic stimulation for negative symptoms in schizophrenia.…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia [NA]
Clinical trial NCT06599372 is currently recruiting to evaluate the efficacy of transcranial magnetic stimulation for resistant auditory verb…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Interest of EMDR Schizophrenic Disorders
A clinical trial evaluating EMDR for schizophrenia sponsored by Hôpital NOVO has terminated.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia [Phase 3]
Phase 3 randomized, double-blind head-to-head trial comparing Carliprazine with Aripiprazole in adults with schizophrenia; status is not yet…
-
FDA approval · 2024-09-12FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., resulting in updated labelin…
-
FDA approval · 2024-09-12FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
FDA approved a supplemental application for Invega Hafyera (paliperidone palmitate) from Janssen Pharmaceuticals, Inc., updating the product…
-
FDA approval · 2024-09-09FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for risperidone by Amneal Pharmaceuticals LLC to bring a generic version of the medication to market…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: In-person vs. Remote Wellness Support [NA]
A completed clinical trial comparing in-person versus remote wellness support for major depressive disorder, bipolar disorder, schizoaffecti…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Medication Reviews in Severe Mental Illness [NA]
A completed clinical trial update from a Danish psychiatric research unit on medication reviews in severe mental illness, including schizoph…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations [NA]
This clinical trial update reports on the efficacy and feasibility of a cognitive-behavioral module designed to reduce distress from auditor…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine [NA]
This clinical trial evaluates whether structured exercise improves clinical symptoms, cognitive performance, and quality of life in schizoph…
-
CLINICAL_TRIALS withdrawal · 2024-08-22Clinical Trial Update: REtinal and VIsual Cortical Response in Early PSYchosis [NA]
The clinical trial 'REtinal and Visual Cortical Response in Early PSYchosis' has been terminated. It studied retinal and visual cortical res…
-
FDA approval · 2024-08-21FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for a generic Lurasidone hydrochloride product, authorizing a generic version of l…